abstract |
The present invention relates to 4-pyridinone compounds that are inhibitors of catechol O-methyltransferase (COMT) and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases involving the COMT enzyme. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved. |